CJC-1295 with DAC

CJC-1295 with DAC is a synthetic analog of growth hormone–releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) to extend plasma stability and receptor interaction duration in experimental models. It binds to GHRH receptors and is studied for its role in somatotropic axis modulation and growth hormone regulatory signaling. Preclinical research utilizes CJC-1295 with DAC to investigate prolonged receptor activation kinetics, downstream intracellular signaling cascades, and peptide-mediated endocrine pathway regulation under controlled laboratory conditions.

For research use only. Not for human consumption.